Kymera Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Kymera Therapeutics Inc
TickerKYMR
CIK #0001815442
CUSIP501575104
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address300 Technology Square 2Nd Floor, Cambridge, MA 02139
Source [EDGAR]
CIK Filing 2011 - 2026
[0001815442] 10-K
[0001815442] 10-Q
[0001815442] 3
[0001815442] 4
[0001815442] 8-K
[0001815442] SC 13D
[0001815442] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
T Rowe Price Investment Management Inc Kymera Therapeutics Inc [2026-05-15] 0.0
FMR LLC Kymera Therapeutics Inc [2024-11-12] 0.0
Baker Bros Advisors LP Kymera Therapeutics Inc [2024-04-01] 0.8
Avoro Capital Advisors LLC Kymera Therapeutics Inc [2023-02-14] 7.0
Baker Bros Advisors LP Kymera Therapeutics Inc [2023-02-14] 5.2
State Street Corp Kymera Therapeutics Inc [2023-02-08] 5.19
Price T Rowe Associates Inc /MD/ Kymera Therapeutics Inc [2022-02-14] 6.9
Vanguard Group Inc Kymera Therapeutics Inc [2022-02-10] 5.75
Wellington Management Group LLP Kymera Therapeutics Inc [2022-02-04] 5.24
BlackRock Inc Kymera Therapeutics Inc [2022-02-04] 6.6
Redmile Group LLC Kymera Therapeutics Inc [2021-02-16] 6.1
Atlas Venture Fund X LP Kymera Therapeutics Inc [2021-02-16] 17.9
FMR LLC Kymera Therapeutics Inc [2021-02-08] 0.0
Vertex Pharmaceuticals Inc / Ma Kymera Therapeutics Inc [2020-09-03] 7.1
Biotechnology Value Fund L P Kymera Therapeutics Inc [2020-08-25] 3.1
Form 3/4/5 Filer 2011 - 2026
Kymera Therapeutics Inc
Mainolfi Nello
Jacobs Bruce N
Goodman Noah
Booth Bruce
BVF Inc/IL
Biotechnology Value Trading Fund OS LP
BVF Partners L P/IL
Lampert Mark N
BVF GP Holdings LLC
BVF II GP LLC
BVF Partners OS Ltd
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
BVF I GP LLC
Esposito Pamela
Baker Brothers Life Sciences LP
Baker Bros Advisors GP LLC
667 LP
Baker Julian
Baker Felix
Baker Bros Advisors LP
Hrustanovic Gorjan
Ridloff Elena
Maraganore John
Albers Jeffrey W
Sandor Victor
Chadwick Jeremy G
Gollob Jared
Adams Brian
Chiniara Ellen
Morgan Leigh
Horobin Joanna
Atlas Venture Fund X LP
Atlas Venture Associates X LLC
Atlas Venture Associates X LP
Atlas Venture Opportunity Fund I LP
Atlas Venture Associates Opportunity I LLC
Atlas Venture Associates Opportunity I LP
Caughey Elaine
Nicholson Donald William
Chesworth Richard
Hall Steven Edward
Wellington Biomedical Innovation Master Investors Cayman I
Redmile Group LLC
Green Jeremy
Alexandria Venture Investments LLC
Hedin Andrew
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Chadwick Jeremy G
Common Stock
2026-03-25 Sell 24,727 $80.26 1,984,589
Chadwick Jeremy G
Common Stock
2026-03-25 Option exercise 24,727 $29.64 732,908
Chadwick Jeremy G
Stock Option (Right to Buy) · derivative
2026-03-25 Option exercise 24,727 $0.00
Chadwick Jeremy G
Common Stock
2026-03-23 Sell 1,200 $80.05 96,060
Chadwick Jeremy G
Stock Option (Right to Buy) · derivative
2026-03-23 Option exercise 84,400 $0.00
Chadwick Jeremy G
Common Stock
2026-03-23 Option exercise 84,400 $29.64 2,501,616
Chadwick Jeremy G
Common Stock
2026-03-23 Sell 52,975 $77.21 4,090,200
Chadwick Jeremy G
Common Stock
2026-03-23 Sell 8,214 $78.40 643,978
Chadwick Jeremy G
Common Stock
2026-03-23 Sell 22,756 $76.73 1,746,068
Chadwick Jeremy G
Common Stock
2026-03-23 Sell 6,105 $79.87 487,606
Esposito Pamela
Common Stock
2026-03-20 Sell 700 $77.71 54,397
Esposito Pamela
Common Stock
2026-03-20 Option exercise 2,500 $49.10 122,750
Esposito Pamela
Common Stock
2026-03-20 Sell 600 $79.24 47,544
Esposito Pamela
Stock Option (Right to Buy) · derivative
2026-03-20 Option exercise 2,500 $0.00
Esposito Pamela
Common Stock
2026-03-20 Sell 1,200 $79.94 95,928
Chadwick Jeremy G
Common Stock
2026-03-11 Sell 11,111 $83.72 930,213
Chadwick Jeremy G
Common Stock
2026-03-11 Sell 1,765 $82.13 144,959
Chadwick Jeremy G
Common Stock
2026-03-11 Sell 12,882 $83.10 1,070,494
Chadwick Jeremy G
Common Stock
2026-03-11 Option exercise 20,000 $43.50 870,000
Chadwick Jeremy G
Stock Option (Right to Buy) · derivative
2026-03-11 Option exercise 20,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 259 84,954,982
2025-12-31 258 83,361,927
2025-09-30 213 75,565,865
2025-06-30 212 72,126,317
2025-03-31 178 66,688,667
2024-12-31 182 64,930,145
2024-09-30 177 62,655,957
2024-06-30 158 61,214,338
2024-03-31 165 62,527,255
2023-12-31 138 54,701,693
2023-09-30 123 50,672,218
2023-06-30 130 51,620,081
Form 13F Holdings
Firm Period DFND Voting Shares
Peregrine Capital Management LLC [2026-06-30] SOLE 16,955 45,671
Moody Aldrich Partners LLC [2026-06-30] SOLE 13,065 30,006
Keudell/Morrison Wealth Management [2026-06-30] SOLE 0 5,215
PSP Research LLC [2026-06-30] SOLE 0 4,000
Gamma Investing LLC [2026-06-30] DFND 454 454
IFP Advisors LLC [2026-06-30] SOLE 219 219
Farther Finance Advisors LLC [2026-06-30] SOLE 0 178
Versant Capital Management Inc [2026-06-30] SOLE 101 101
Fortitude Family Office LLC [2026-06-30] SOLE 41 41
Torren Management LLC [2026-06-30] SOLE 0 24
Handelsbanken Fonder AB [2026-06-30] SOLE 0 20
JFS Wealth Advisors LLC [2026-06-30] SOLE 0 14
Physician Wealth Advisors Inc [2026-06-30] SOLE 0 7
Marquette Asset Management LLC [2026-06-30] SOLE 0 6
Dinuzzo Private Wealth Inc [2026-06-30] SOLE 0 5
GHP Investment Advisors Inc [2026-06-30] SOLE 3 3
Hughes Financial Services LLC [2026-06-30] SOLE 3 3
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com